- DocumentoD'OXYVA Prof. Puruhito Interview Articlecaricato daCircularity Healthcare
- DocumentoD'OXYVA Peripheral Edema and Transdermal-CO2caricato daCircularity Healthcare
- DocumentoD'OXYVA Patient Generalcaricato daCircularity Healthcare
- DocumentoD'OXYVA Information Summary for Healthcare Professionals_proofreadV3 W.O Commentscaricato daCircularity Healthcare
- DocumentoNon-invasive Transdermal Delivery of Medical Carbon Dioxide with D`OXYVA® Boosts Microcirculation, Balances Parasympathetic/Sympathetic Nerve Activitycaricato daCircularity Healthcare
- DocumentoNon-invasive Transdermal Delivery of Medical Carbon Dioxide with D`OXYVA® Boosts Microcirculation, Balances Parasympathetic/Sympathetic Nerve Activitycaricato daCircularity Healthcare
- DocumentoNon-invasive Transdermal Delivery of Medical Carbon Dioxide with D`OXYVA® Boosts Microcirculation, Balances Parasympathetic/Sympathetic Nerve Activitycaricato daCircularity Healthcare
- DocumentoCE Mark for D'OXYVA Obtained by Circularity Healthcare, Sales to Customers in the European Union Commencescaricato daCircularity Healthcare
- DocumentoIndustry-Leading Noninvasive Transdermal Microcirculatory Technology for Rapid Closure of Complex Wounds with Significant Pain Reliefcaricato daCircularity Healthcare